United States · Funded startup

Who invested in Reneo Pharmaceuticals

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$105Mraised across 2 rounds since 2019, from 2 sources

$50MSeries A$55MRound
Latest round
Round, $55MMay 2023
Investors
4 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2020202120222023
$50MSeries A$55MRound
First round
Series A, $50M
May 2019
Biggest round
$55M
Round · May 2023
Between rounds
3.9 years
from the last two

The rounds

  1. May 2023
    Round$55M1 returning

    Source recorded

  2. May 2019
    Series A$50M4 new

    Reported by FinSMEsSEC filing: $25M sold, first sale May 2019

Founders and team

From the SEC filings it signed: 4 on the team.

  • Alejandro DorenbaumExecutive Officeri
  • Gregory FlesherExecutive Officer, Directori
  • Mike CruseExecutive Officeri
  • Wendy JohnsonExecutive Officeri

On the board, as filediBali MuralidharEd MathersJohan KordelKenneth HarrisonLon CardonMichael GreyNiall O'DonnellStacey Seltzer

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

New Enterprise AssociatesVC firm2rounds, led 1
RiverVestVC firm1round
Pappas CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Reneo Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Aisling CapitalPrivate equityPer its own site

Quick answers about Reneo Pharmaceuticals

Who invested in Reneo Pharmaceuticals?

Reneo Pharmaceuticals's investors include New Enterprise Associates, RiverVest, Pappas Capital and Lundbeckfonden Ventures.

How much has Reneo Pharmaceuticals raised?

Reneo Pharmaceuticals has raised $105M across 2 rounds since 2019.

When did Reneo Pharmaceuticals last raise?

Reneo Pharmaceuticals's most recent round was an Undisclosed round of $55M in May 2023.

What was Reneo Pharmaceuticals's biggest round?

Its most recent round, $55M in May 2023, is also its largest on record.

Who backed Reneo Pharmaceuticals first?

Reneo Pharmaceuticals's first round on record, in May 2019, was backed by New Enterprise Associates, RiverVest and Pappas Capital and 1 others.

What stage is Reneo Pharmaceuticals at?

Reneo Pharmaceuticals's latest named round is an Undisclosed round, in May 2023.

Where is Reneo Pharmaceuticals based?

Reneo Pharmaceuticals is based in the United States.

Who led Reneo Pharmaceuticals's rounds?

New Enterprise Associates led the Series A in 2019.

Companies like Reneo Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.